2017
DOI: 10.21474/ijar01/5463
|View full text |Cite
|
Sign up to set email alerts
|

Six Years Follow-Up of Low-Level Laser Therapy (Lllt) in Patients With Age-Related Macular Degeneration (Amd).

Abstract: Low-level laser therapy LLLT, agerelated macular degeneration( AMD), fluorescein angiography. Purpose:The objective of this study is to examine long-term effects of low-level laser therapy (LLLT) in patients with age-related macular degeneration (AMD). Methods: The research was implemented for a period of six years. For LLLT, a He-Ne Laser with continuous emission at 633 nm (01 mW/cm2) was used in patients with AMD of all stages (dry to wet exudative forms were included). In total, 33 patients (16 men and 17 w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…Recent reviews describe present understanding of the impact of red–infrared light on the resilience of the skin 14 and in inducing supernormal performance in muscle as well as accelerated recovery from fatigue and injury. 15,16 The use of PBM as a neuroprotectant was pioneered by Eells and colleagues 17 in a model of alcohol-induced degeneration of retinal photoreceptors and has been extended to the slowing of cerebral degenerations, 1824 the mitigation of the effects of traumatic brain injury, 2530 the mitigation of macular degeneration, 31,32 and improvements in the outcome of stroke. 33,34 The value of PBM for the mitigation of retinal damage in a range of conditions has received support from a recent meta-analysis 5 ; the author adds caution that larger scale clinical trials are needed for a fuller understanding of the mechanisms involved.…”
Section: Light and Other Radiationsmentioning
confidence: 99%
“…Recent reviews describe present understanding of the impact of red–infrared light on the resilience of the skin 14 and in inducing supernormal performance in muscle as well as accelerated recovery from fatigue and injury. 15,16 The use of PBM as a neuroprotectant was pioneered by Eells and colleagues 17 in a model of alcohol-induced degeneration of retinal photoreceptors and has been extended to the slowing of cerebral degenerations, 1824 the mitigation of the effects of traumatic brain injury, 2530 the mitigation of macular degeneration, 31,32 and improvements in the outcome of stroke. 33,34 The value of PBM for the mitigation of retinal damage in a range of conditions has received support from a recent meta-analysis 5 ; the author adds caution that larger scale clinical trials are needed for a fuller understanding of the mechanisms involved.…”
Section: Light and Other Radiationsmentioning
confidence: 99%